Medical Rights: Who Decides What You May Put in Your Body

They call you a patient. That word was chosen, and it programs passivity into your identity before you sit down. A patient waits. A patient complies. A patient trusts somebody else to decide what is possible.

I am not telling you to distrust medicine. I am telling you to stop being passive inside it.

The medical system was built for averages, for liability, and to manage disease. You are asking it for performance engineering. Walk in expecting optimization from a machine built for those 3 jobs and you leave disappointed or medicated into compliance.

The legal category almost nobody gets right

Start with the sentence that clears up most of the fear in this space.

“Not FDA approved” does not mean illegal. It means the compound is not authorized for commercial medical marketing, which is a completely different legal category.

A compound that sits outside the scheduled and controlled lists is legal to purchase and possess for personal use in the United States and many other jurisdictions. Peptides, nootropics, research SARMs and experimental metabolic agents sit in that space. They are not approved for a doctor to prescribe as a treatment, and they remain legal to own.

That is literacy. Know what is scheduled. Know what is controlled. Know the difference between forbidden and not commercially promoted, because those 2 things get deliberately blurred and the blur is where the fear lives.

Off-label is the system’s own admission

If you think the approval stamp is the boundary of legitimate use, read what the regulator says about its own product.

The FDA’s position is that once it approves a drug, healthcare providers generally may prescribe that drug for an unapproved use when they judge it is medically appropriate for their patient. A different disease from the one on the label. A different route. A different dose. ^[1]

Sit with what that concedes. The label is a marketing authorization for a specific claim, and the agency that issues it says the treating clinician, working with the patient, decides the actual use. The approval is about what a company may sell and promote. Your treatment was always a judgment made between 2 people, one of whom is you.

Most men who think they are fighting the law are fighting their own assumption about it.

Why good compounds stay unapproved

3 reasons dominate, and none of them is that the molecule failed.

It cannot be patented. A molecule that exists in nature or was discovered too long ago cannot be owned exclusively. No monopoly means no billion-dollar return, and no return means nobody funds the approval process.

That process is the part people underestimate. The best-known estimate of what it takes to bring one new drug through, built from R&D data on 106 randomly selected compounds from 10 pharmaceutical firms, puts the total capitalized pre-approval cost at $2.558 billion in 2013 dollars. ^[2] Nobody spends that on a molecule they cannot own.

It competes with an existing profit centre. A compound that outperforms a drug already earning billions is a threat to that revenue, and companies protect revenue. Sometimes that means a better option sits in regulatory limbo indefinitely.

It threatens the subscription model. This is the reason that gets left out of the polite version. A compound that resolves a problem is worth 1 sale. A compound that manages a symptom is worth a lifetime subscription. The medical economy runs on chronic treatment, so anything built to end a condition instead of maintaining it attacks that revenue at the root.

None of that requires a conspiracy. It requires only that money flows toward return, which it does, every time, without anybody in a room agreeing to it. Patent holders fund the trials that get run and staff the panels that decide what is worth testing. The box for the cheap unpatentable competitor does not stay empty by accident.

Now the part that has to travel with all of it. Unapproved also means untested at scale, and the unknowns run in both directions. The gray zone rewards the informed and punishes the casual. Anyone who gives you the incentive argument without that sentence attached is selling you something.

I went through how this plays out with a specific class of compounds in my breakdown of the peptide compounding restrictions, where the stated reason and the structural reason point in different directions.

Informed consent is the leverage you already have

Informed consent means you make your own decisions once the risks, benefits and alternatives have been explained to you. It is the legal and ethical foundation of the entire clinical encounter, and it belongs to you rather than to the clinician.

A good clinician respects an adult who arrives and says: here is my risk tolerance, here is what I am monitoring, here is the outcome I want, here is the point at which I stop if things go wrong.

That is how professionals operate in every other field where risk is real. Freedom and responsibility travel together. The adult who accepts the risk owns the decision, and owning it means stating in advance what would make you quit.

You also do not need permission to pursue health. You can seek information. You can get second opinions. You can fire a doctor who treats your questions as rebellion. None of that is illegal and none of it is unethical. The best patients already do exactly this. They just do not call it biohacking.

The system respects paperwork more than passion

Walk in emotional and vague and you get dismissed. Walk in with organized data and you get taken seriously. That is triage under time pressure.

Build the file before the appointment: 1 page of goals in plain language, a dated symptom timeline with severity, what you have already tried and what happened, lab results in order with the trends marked, and vitals you track yourself.

Then use questions that force precision instead of reassurance. What result would change your recommendation? What is the differential? If this marker rises, what do we do next? What is the monitoring schedule? A clinician who cannot answer those is guessing, and you can find another one without making it a fight.

And when you are told your labs are normal, understand what that word is doing. Normal is a population statistic. It tells you where the herd sits rather than where you function. The clean response keeps it clinical: I am less focused on the label and more interested in resolving the symptoms, so what else can we test or rule out?

There are 5 lanes of care

Standard primary care is 1 lane of 5, and it is the worst of them for optimization.

Specialists run deeper workups. Performance and longevity clinics are goal-oriented and monitoring-heavy. Compounding routes exist for when standard forms and doses do not fit. Clinical trials are high-paperwork and high-structure and they carry access to things that are not available any other way.

Lane 1 gets mistaken for the whole highway. Then a man concludes the system has nothing for them, and go underground, which is the worst outcome available. If your path requires secrecy and chaos, you are not optimizing. You are gambling.

The version that protects you costs nothing: use licensed providers and legitimate labs, keep clean records of every test and communication, monitor continuously instead of setting and forgetting, and change 1 variable at a time so you know what caused what.

Sovereignty is a standard you meet

You do not win medical freedom by yelling at the system. You win it by becoming too organized, too informed and too well-monitored to be dismissed.

And the last rule matters more than any of the others: nobody becomes your hero. Your clinician, your coach, your lab and your community exist to execute your mission with checks on it. The moment you outsource your judgment to a guru or a clinic or a protocol, you handed away the exact thing this chapter is about.

I run that check in public. The room where I take it apart with other men, including the parts I have gotten wrong, is the free community, and the disagreement in there is the point of it.

Your body. Your mission. Your command.

—

Drawn from Chapter 15, Your Medical Rights in the Age of Enhancement, of Better Than Natural: The Engineered Human Manifesto. The full Enhanced Patient File template, the 5 lanes of care, and the provider vetting questions are in the book.

Sources

1. U.S. Food and Drug Administration, Understanding Unapproved Use of Approved Drugs “Off Label”, https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-unapproved-use-approved-drugs-label
2. DiMasi JA, Grabowski HG, Hansen RW, 2016, Journal of Health Economics 47:20-33, PMID 26928437